AVASTIN KILLS!!!

Quote

Anonymous

Guest
Genentech Suspents Recruitment in Avastin Trial

By TSC Staff
2/13/2006 7:38 AM EST


Genentech (DNA:NYSE - commentary - research - Cramer's Take) suspended new recruitment in a year-old trial of its Avastin drug in colon cancer after several patients in the study died.
 






Hey Potential DNA Options Millionaires!

Where's all your trash talk now?

Just heard the news...so now you expect a dying cancer patient to pay the last of his or her life savings just to die all that quicker. Maybe you should change the name from Avastin to Kevorkian.

Enjoy your low base, lousy bonus and dwindling options...I'll be waving to you from my yacht.

The Frog
 






[ QUOTE ]
Hey Potential DNA Options Millionaires!

Where's all your trash talk now?

Just heard the news...so now you expect a dying cancer patient to pay the last of his or her life savings just to die all that quicker. Maybe you should change the name from Avastin to Kevorkian.

Enjoy your low base, lousy bonus and dwindling options...I'll be waving to you from my yacht.

The Frog

[/ QUOTE ]

Hey Frog

Yeah. The market is so concerned that the stock is down a whole buck. Now my options are worth only 975k. This price won't stop me from buying ESOP shares at $40. I'll take my 105k base and 60k bonus and shut up. Maybe I'll go to the board with all the rich folks like you. Got a job on a yacht, huh? Nice to finally get the job after three tries.
 






I believe the Frog is right. And by the way, you're pretty much full of crap with your numbers. I've worked here for five years and am nowhere near your numbers...and I've been a high performer.

If anything you're an Amgen rep trolling our board. Those of us in the know here realize there's a bumpy road ahead.

And speaking of yachts: I heard the Frog was having a little fun with your wife out there. She was climbing up his mast, if you know what I mean and I think you do!
 






[ QUOTE ]
[ QUOTE ]
Hey Potential DNA Options Millionaires!

Where's all your trash talk now?

Just heard the news...so now you expect a dying cancer patient to pay the last of his or her life savings just to die all that quicker. Maybe you should change the name from Avastin to Kevorkian.

Enjoy your low base, lousy bonus and dwindling options...I'll be waving to you from my yacht.

The Frog

[/ QUOTE ]

Hey Frog

Yeah. The market is so concerned that the stock is down a whole buck. Now my options are worth only 975k. This price won't stop me from buying ESOP shares at $40. I'll take my 105k base and 60k bonus and shut up. Maybe I'll go to the board with all the rich folks like you. Got a job on a yacht, huh? Nice to finally get the job after three tries.

[/ QUOTE ]

Okay, so I was exagerrating about my numbers. In reality I make 68k base and made ablut 30k in bonus last year. And by the time I can exercise my options they certainly won't be worth anything like I posted.

And please Mr. Frog sir, do anything with my wife you please. I deserve it for being such a panty-waisted little ferry.
 






The deaths were in the combination arm with Folfox you idiot!!! The trial was enrolling at over 200 patients a month so they decided to suspend enrollment, not the entire trial. Read next time before you post.
 






Tysabri...Vioxx...AVASTIN?!


Please put patients first! We know from your postings that you are all consumed by greed (the above "options" poster serves as proof) but please think about the greater good of mankind, especially cancer patients.
 


















NEW YORK Doctors are excited about the prospect of Avastin, a drug already widely used for colon cancer, as a crucial new treatment for breast and lung cancer, too. But doctors are cringing at the price the maker, Genentech, plans to charge for it: about $100,000 a year.

The Frog was right.
 






[ QUOTE ]
NEW YORK Doctors are excited about the prospect of Avastin, a drug already widely used for colon cancer, as a crucial new treatment for breast and lung cancer, too. But doctors are cringing at the price the maker, Genentech, plans to charge for it: about $100,000 a year.

The Frog was right.

[/ QUOTE ]

Senor Frog needs to croak, after he gets his facts right!
 






At least the Frog puts people before profits, humanity before options.

You are a lowlife for worshipping the almighty dollar, and in the end you will grovel for your transgressions...alll for a few measly bucks.
 


















Avastin is not perfect but, which product is. It does help many people live longer and better. Asprin kills more people each year but, it still helps people. That's what pharma products do, they help most people and have some side effects too. Risk-reward. I would take either product, Avastin if needed or Asprin if needed.
 






Anonymous said:
Avastin is not perfect but, which product is. It does help many people live longer and better. Asprin kills more people each year but, it still helps people. That's what pharma products do, they help most people and have some side effects too. Risk-reward. I would take either product, Avastin if needed or Asprin if needed.
Click to expand...

And your whole point is?
 






Avastin is a terrible drug whose deadly side effects outweigh the very slight chance of a benefit of prolonging life. Read the facts, this drug isn't doing what Genentech reported it would do. It was pulled for breast cancer..it will be pulled for other uses to because it kills.
 












Anonymous said:
Hey Potential DNA Options Millionaires!

Where's all your trash talk now?

Just heard the news...so now you expect a dying cancer patient to pay the last of his or her life savings just to die all that quicker. Maybe you should change the name from Avastin to Kevorkian.

Enjoy your low base, lousy bonus and dwindling options...I'll be waving to you from my yacht.

The Frog
Click to expand...

The are no "DNA" options! We are Roche now, with a fancy name is the US. Genentech the Corporation is no longer in business. All DNA shares were purchased by Roche, when they overpaid for us aboiy 6 years ago. AndYES, I made out like a bandit.
 






Anonymous said:
Avastin is a terrible drug whose deadly side effects outweigh the very slight chance of a benefit of prolonging life. Read the facts, this drug isn't doing what Genentech reported it would do. It was pulled for breast cancer..it will be pulled for other uses to because it kills.
Click to expand...

FDA approved it because it was from Genentech, an American born company. If it was Bayer, it would of been rejected. Even during clinical trials it proved to be lethal. The drug was supposed to be and advertised as something that targets only cancer cells. Instead, it also kills healthy cells. It does not discriminate. Why not just inject yourself with cyanide.
 






Top Bottom
Back
Quote